Luderer J R, Patel I H, Durkin J, Schneck D W
Clin Pharmacol Ther. 1984 Jan;35(1):19-25. doi: 10.1038/clpt.1984.3.
One gram ceftriaxone was injected at a constant rate in an intravenous infusion over 30 min to eight elderly subjects (mean age, 70.5 yr) and eight young subjects (mean age, 28.9 yr); the latter served as body weight-matched controls. Plasma and urine samples were collected in serial order for 48 hr and assayed for unchanged drug. Selected plasma samples were subjected to protein binding determinations by equilibrium dialysis. Statistical comparison of data for the old and young indicated no significant changes in means of (1) maximum plasma concentration (140 and 133 micrograms/ml); (2) elimination rate constant (0.078 and 0.093 hr-1) and elimination t1/2 (8.9 and 7.5 hr); (3) apparent volume of distribution (10.69 and 11.01 l); (4) plasma clearance (833 and 1023 ml/hr); (5) nonrenal clearance (515 and 606 ml/hr); and (6) percent dose excreted unchanged in urine (39.6 and 41.4). There was, however, a significant decrease in the renal clearance (318 and 416 ml/hr) and a significant increase in the plasma free fractions (0.157 and 0.136 at 100 micrograms/ml and 0.146 and 0.114 at 60 to 70 micrograms/ml) of ceftriaxone in elderly subjects. The 24% decrease in renal clearance in the elderly subjects corresponded to the 19% decrease in their creatinine clearance. Since the age-related changes in kinetics were relatively small, it is concluded that dosage adjustment is probably not necessary for elderly subjects requiring ceftriaxone.
以恒定速率在30分钟内静脉输注1克头孢曲松,给药对象为8名老年受试者(平均年龄70.5岁)和8名年轻受试者(平均年龄28.9岁);后者作为体重匹配的对照。连续48小时按顺序采集血浆和尿液样本,检测其中未变化的药物。选择的血浆样本通过平衡透析进行蛋白结合测定。老年组和年轻组数据的统计学比较表明,以下各项均值无显著变化:(1)最大血浆浓度(140和133微克/毫升);(2)消除速率常数(0.078和0.093小时-1)及消除半衰期(8.9和7.5小时);(3)表观分布容积(10.69和11.01升);(4)血浆清除率(833和1023毫升/小时);(5)非肾清除率(515和606毫升/小时);(6)尿液中以原形排泄的剂量百分比(39.6和41.4)。然而,老年受试者头孢曲松的肾清除率显著降低(318和416毫升/小时),血浆游离分数显著升高(100微克/毫升时为0.157和0.136,60至70微克/毫升时为0.146和0.114)。老年受试者肾清除率降低24%,与其肌酐清除率降低19%相对应。由于与年龄相关的动力学变化相对较小,得出结论:对于需要使用头孢曲松的老年受试者,可能无需调整剂量。